Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Earnings [Member]	Accumulated Other Comprehensive (Loss) Income [Member]
Common stock, shares, beginning balance at Dec. 31, 2022		106,609,000
Stockholders' equity, beginning balance at Dec. 31, 2022	$ 5,836,055	$ 107	$ 2,887,476	$ 3,140,289	$ (191,817)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	830,777			830,777
Other comprehensive (loss) income	17,686				17,686
Common stock issued for share-based compensation, shares		392,000
Common stock issued for share-based compensation	0	$ 0	0
Tax withholding related to vesting of restricted stock, shares		(154,000)
Tax withholding related to vesting of restricted stock	(31,130)	$ 0	(31,130)
Share-based compensation expense	34,081		34,081
Common stock, shares, ending balance at Dec. 31, 2023		106,847,000
Stockholders' equity, ending balance at Dec. 31, 2023	6,687,469	$ 107	2,890,427	3,971,066	(174,131)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,292,044			1,292,044
Other comprehensive (loss) income	(9,927)				(9,927)
Common stock issued for share-based compensation, shares		341,000
Common stock issued for share-based compensation	0	$ 0	0
Tax withholding related to vesting of restricted stock, shares		(128,000)
Tax withholding related to vesting of restricted stock	(20,178)	$ 0	(20,178)
Share-based compensation expense	$ 28,169		28,169
Common stock, shares, ending balance at Dec. 31, 2024	107,060,281	107,060,000
Stockholders' equity, ending balance at Dec. 31, 2024	$ 7,977,577	$ 107	2,898,418	5,263,110	(184,058)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,528,229			1,528,229
Other comprehensive (loss) income	28,592				28,592
Common stock issued for share-based compensation, shares		350,000
Common stock issued for share-based compensation	0	$ 0	0
Tax withholding related to vesting of restricted stock, shares		(100,000)
Tax withholding related to vesting of restricted stock	(15,525)	$ 0	(15,525)
Share-based compensation expense	$ 19,120		19,120
Common stock, shares, ending balance at Dec. 31, 2025	107,309,794	107,310,000
Stockholders' equity, ending balance at Dec. 31, 2025	$ 9,537,993	$ 107	$ 2,902,013	$ 6,791,339	$ (155,466)